arrow
S

Suzette Delaloge

gustave roussy
H指数:88
被引数:3.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Randomised phase III trials of cancer prevention drugs: a systematic review and prediction of trial success☆

癌症预防药物的随机III期临床试验:一项系统综述和试验成功的预测<a class="anchor anchor-primary" href="#fn1" name="bfn1" data-sd-ui-side-panel-opener="true" data-xocs-content-type="reference" data-xocs-content-id="fn1"><span class="anchor-text-container"><span class="anchor-text"><sup>☆</sup></span></span></a>

2026-09-090
OAAI
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER)☆

卵巢储备作为激素受体阳性(HR阳性)、HER2阴性、淋巴结阳性乳腺癌中辅助化疗获益的衡量指标(SWOG S1007[RxPONDER])

2026-07-240
PRE
Primary results from EL1SSAR, a prospective phase IIIb study of first-line atezolizumab plus nab-paclitaxel therapy for patients with PD-L1-positive advanced triple-negative breast cancer

EL1SSAR前瞻性IIIb期研究初步结果:PD-L1阳性晚期三阴性乳腺癌患者一线阿替利珠单抗联合白蛋白结合型紫杉醇治疗的疗效评估

2026-06-080
OAAI
Recent treatment and survival trends in older versus younger women with HR-positive HER2-negative metastatic breast cancer in the real-life multicenter French ESME cohort

老年与年轻HR阳性HER2阴性转移性乳腺癌女性患者真实世界多中心法国ESME队列中的近期治疗与生存趋势

2025-12-050
PRE
Letrozole to prevent breast cancer in postmenopausal women with BRCA1/2 mutations (LIBER study)

来曲唑预防携带BRCA1/2突变的绝经后女性乳腺癌(LIBER研究)

2025-11-070
PRE
Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancers
2025-07-290
OAAI
Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER+/HER2- breast cancer

早期治疗期间循环肿瘤DNA的演变在晚期ER+/HER2-乳腺癌中的预后意义

2025-07-050
PRE
Acceptability of risk-based breast cancer screening among professionals and healthcare providers from 6 countries contributing to the MyPeBS study (vol 25, 483, 2025)

来自6个国家的专业人员和医疗保健提供者基于风险的乳腺癌筛查的可接受性MyPeBS研究 (第25卷,483,2025)

2025-04-140
OAAI
Acceptability of risk-based breast cancer screening among professionals and healthcare providers from 6 countries contributing to the MyPeBS study

参与MyPeBS研究的6个国家的专业人员和医疗保健提供者对基于风险的乳腺癌筛查的可接受性

2025-03-151
OAAI
Breast imaging readers' performance in the PERFORMS test-set based assessment scheme within the MyPeBS international randomised study

乳腺成像读者在MyPeBS国际随机研究中执行基于测试集的评估方案中的表现

2025-02-010
OAAI
Tertiary cancer prevention: A national evaluation of the practices and perceptions of hospital-based health care professionals (HHCPs) in charge of the follow-up (FU) care of cancer

三级癌症预防:一项针对负责癌症随访(FU)护理的医院-based卫生保健专业人员(HHCPs)的实践和认知的国家评估

2024-12-010
PRE